CAS: 5018-30-4; Dimethyl Methoxymalonate

相似化合物

80-69-3 761-06-8 113137-33-0

上下游产品

CAS号67-56-1 甲醇 | CAS号6773-29-1 重氮丙二酸二甲酯 | CAS号84212-88-4 1-chloro-1,2,2,... | CAS号108-59-8 丙二酸二甲酯 | CAS号34297-79-5 dibenzothiophen... | CAS号72932-82-2 benzothiopheniu... | CAS号63196-84-9 Thiophenium, 2-... | CAS号553-90-2 草酸二甲酯 | CAS号6290-49-9 甲氧基乙酸甲酯 | CAS号1107692-57-8 dimethyl 2-(2,4... | CAS号108-59-8 丙二酸二甲酯 | CAS号5193-84-0 4,6-二羟基-5-甲氧基嘧啶 | CAS号113137-33-0 2,3-dimethoxy-3... | CAS号761-06-8 2-methoxypropan... | CAS号848245-33-0 2-(4-羟基苄基)-2-甲氧... | CAS号5018-31-5 2-甲氧基丙二酰胺 | CAS号40924-27-4 diethyl 2-metho...

甲氧基乙酸甲酯 反应生成 甲氧基马来酸二甲酯
参考文献:Ledon,H. Et Al.,Bulletin De La Societe Chimique De France,1973,P. 2065-2071
标题:Ledon,H. Et Al.,Bulletin De La Societe Chimique De France,1973,P. 2065-2071

专利信息

专利号:US-11859023-B2
优先权日:2020-07-08
标 题:Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof
发明人：ARNOLD JEFFREY; RALPH DAVID A
权利人:NAVIDEA BIOPHARMACEUTICALS INC
摘要:Disclosed herein is method for conjugating a metal chelating agent to a functionalized dextran by reacting a chelator with an aminated dextran backbone, where the chelator comprises a one, and only one, derivatized carboxylic acid group to form a chelator-dextran complex. In certain aspects, the dextran-chelator complex is substantially free of intra- or intermolecular crosslinking. In certain aspects, the functionalized dextran is an amine dextran, an alkynyl dextran, or a thiol dextran. In exemplary implementations, the functionalized dextran is an amine dextran. In further embodiments, one and only one carboxylic acid group on the chelating agent is derivatized as a N-hydroxysuccinimide (NHS) ester.

专利号:US-2022010036-A1
优先权日:2020-07-08
标题 :Synthesis of uniformly defined molecular weight mannosylated dextrans and derivatives thereof

专利号:US-2015366976-A1
优先权日:2011-11-11
标 题:Injectable filler
发明人：NGUYEN PHI; PHAN LOC; TRAN BAO
权利人:NGUYEN PHI; PHAN LOC; TRAN BAO; MIBA MEDICAL INC
摘要:A method for producing an HA gel slurry having a plurality of cross-linked units each formed by providing an inner core using a non-biological synthesis process; and cross-linking at a first cross-link strength using a hyaluronic acid (HA) or glycosaminoglycan (GAG) made from a biological synthesis process followed by additional cross-linkings at a second cross-link strength with HA or GAG, wherein the first cross-link strength is stronger than the second cross-link strength.

专利号:CN-114874221-A
优先权日:2022-05-12
标 题:A kind of RIP2 kinase inhibitor intermediate and its synthesis method